SecBot SecBot
SECBOTREPLAY Home › Report › RDY

RDY · Dr

DR REDDYS LABORATORIES LTD · 6-K filed Jul 29, 2026 at 14:00 ET

At the news

NEUTRALIMPACT 4/10

6-K filed Jul 29, 2026 at 14:00 ET

Dr. Reddy's disclosed that the USFDA completed a 10-day Pre-Approval Inspection (PAI) and GMP inspection at its FTO-SEZ Process Unit-02 in Srikakulam, Andhra Pradesh, from July 20-29, 2026. The company received a Form 483 with three observations, which it will address within the stipulated timeline. This is a routine regulatory event with no material financial impact disclosed, but the three observations introduce minor regulatory risk for the facility's compliance status and potential product approvals tied to the PAI.

  • USFDA completed a Pre-Approval Inspection (PAI) and GMP inspection at Dr. Reddy's FTO-SEZ Process Unit-02 in Srikakulam, Andhra Pradesh from July 20 to July 29, 2026.
  • The company received a Form 483 with three observations, which it will address within the stipulated timeline.
  • No financial figures, revenue impact, or material operational disruptions were disclosed in the filing.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access